• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 5. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565

• Solvents and Organic Chemicals Organic Compounds Organosulfur compounds Thioethers Aryl thioethers

Comprehensive Overview of 4-Propylsulfanylphenylboronic Acid (CAS No. 279261-73-3): Properties, Applications, and Industry Trends

4-Propylsulfanylphenylboronic acid (CAS No. 279261-73-3) is a specialized boronic acid derivative that has garnered significant attention in pharmaceutical and materials science research. This compound, characterized by its propylsulfanyl and phenylboronic acid functional groups, serves as a versatile building block in organic synthesis and drug development. Its unique structure enables applications in Suzuki-Miyaura cross-coupling reactions, a widely used method for forming carbon-carbon bonds in medicinal chemistry.

The growing demand for boronic acid-based compounds like 4-Propylsulfanylphenylboronic acid is driven by their role in designing targeted therapies and bioconjugation strategies. Researchers are particularly interested in its potential for creating enzyme inhibitors and proteolysis-targeting chimeras (PROTACs), which align with current trends in precision medicine. The compound's sulfur-containing moiety also contributes to enhanced cell permeability, making it valuable for bioactive molecule development.

From a synthetic chemistry perspective, CAS 279261-73-3 demonstrates excellent stability under various reaction conditions while maintaining high reactivity in palladium-catalyzed couplings. This balance makes it ideal for constructing complex heterocyclic scaffolds found in many FDA-approved drugs. Recent publications highlight its utility in developing kinase inhibitors, particularly for oncology research where signal transduction modulation is crucial.

The materials science sector utilizes 4-Propylsulfanylphenylboronic acid for creating functionalized polymers with responsive properties. Its boronic acid group enables dynamic covalent chemistry applications, including self-healing materials and glucose-sensitive hydrogels for biomedical devices. These innovations address the increasing need for smart biomaterials in wearable health monitors and controlled drug delivery systems.

Quality control of 279261-73-3 involves rigorous HPLC analysis and spectroscopic characterization (1H/13C NMR, FT-IR) to ensure purity for sensitive applications. Suppliers typically provide technical data sheets detailing storage conditions (recommended 2-8°C under inert atmosphere) and handling precautions to maintain stability. The compound's structure-activity relationships continue to be explored through computational modeling and high-throughput screening platforms.

Emerging environmental considerations have prompted studies on green chemistry approaches for synthesizing boronic acid derivatives. Researchers are investigating catalyst recycling methods and aqueous-phase reactions to improve the sustainability profile of compounds like 4-Propylsulfanylphenylboronic acid. These developments respond to the pharmaceutical industry's push toward eco-friendly synthesis while maintaining cost-effectiveness.

Patent analysis reveals growing intellectual property activity around 279261-73-3 derivatives, particularly in bioconjugation technologies and diagnostic reagents. The compound's ability to form stable boronate esters with diols makes it valuable for developing biosensors targeting biomarkers like sialic acid or catecholamines. This aligns with diagnostic trends toward point-of-care testing and liquid biopsy platforms.

Market analysts project steady growth for the boronic acid sector, with 4-Propylsulfanylphenylboronic acid maintaining relevance due to its structural versatility. Custom synthesis services now offer isotope-labeled versions (11B/1?B) for metabolic studies and PEGylated derivatives for improved pharmacokinetics. These value-added products cater to the expanding theranostics market combining therapeutic and diagnostic functions.

For researchers sourcing CAS 279261-73-3, key considerations include batch-to-batch consistency and certificates of analysis documenting residual solvent levels and heavy metal content. Reputable suppliers provide scale-up capabilities from milligram to kilogram quantities with GMP-compliant options for preclinical development. The compound's structure-property database continues to expand through collaborative open science initiatives in chemical biology.

Future research directions for 4-Propylsulfanylphenylboronic acid may explore its supramolecular chemistry applications or potential in covalent organic frameworks (COFs). The compound's dual lipophilic/hydrophilic character makes it particularly interesting for membrane transport studies and blood-brain barrier penetration research. These investigations support the broader pharmaceutical industry's focus on CNS drug discovery and neurotherapeutics development.

• 145349-76-4(4-(ethylthio)phenylboronic acid)
• 362045-33-8(2-Ethylthiophenylboronic acid)
• 380427-38-3((p-Isopropylthiophenyl)boronic Acid)
• 1217501-03-5(4-(Cyclopropylmethylthio)phenylboronic acid)
• 1256346-42-5((3-(Cyclobutylthio)phenyl)boronic acid)
• 411229-80-6(4-Cyclopropylthiophenylboronic acid)
• 1217501-05-7(3-(t-Butylthio)phenylboronic acid)
• 820972-68-7(4-(tert-Butylthio)phenylboronic Acid)
• 870718-05-1(3-Ethylthiophenylboronic acid)
• 1217500-97-4(4-(Isobutylthio)phenylboronic acid)